Nanoparticle-Mediated Delivery of STAT3 Inhibitors in the Treatment of Lung Cancer
Lung cancer is a common malignancy worldwide, with high morbidity and mortality. Signal transducer and activator of transcription 3 (STAT3) is an important transcription factor that not only regulates different hallmarks of cancer, such as tumorigenesis, cell proliferation, and metastasis but also r...
Saved in:
Main Authors: | Qiyi Feng (Author), Kai Xiao (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biodegradable Nanoparticles Mediated Co-delivery of Erlotinib (ELTN) and Fedratinib (FDTN) Toward the Treatment of ELTN-Resistant Non-small Cell Lung Cancer (NSCLC) via Suppression of the JAK2/STAT3 Signaling Pathway
by: Donglai Chen, et al.
Published: (2018) -
Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain
by: Yaping Hua, et al.
Published: (2022) -
Monoclonal antibody as a targeting mediator for nanoparticle targeted delivery system for lung cancer
by: Nasrul Wathoni, et al.
Published: (2022) -
Mulberrofuran G inhibits proliferation and migration by inactivating JAK2/STAT3 signaling in lung cancer cells
by: Hai-, et al.
Published: (2021) -
Mulberrofuran G inhibits proliferation and migration by inactivating JAK2/STAT3 signaling in lung cancer cells
by: Hai-, et al.
Published: (2021)